| mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.022 |
0.9 |
| mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
0.0088 |
0.9 |
| mRNA |
AMG-706 |
FIMM |
pan-cancer |
AAC |
0.027 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.0078 |
0.9 |